Estrogen receptor signaling as a target for novel breast cancer therapeutics
- 15 February 2013
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 85 (4), 449-465
- https://doi.org/10.1016/j.bcp.2012.10.018
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cellsBreast Cancer Research and Treatment, 2011
- Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosisBreast Cancer Research and Treatment, 2009
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival SignalsCancer Cell, 2009
- The role and regulation of the nuclear receptor co-activator AIB1 in breast cancerBreast Cancer Research and Treatment, 2009
- Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cellsBreast Cancer Research and Treatment, 2008
- Estrogen receptors outside the nucleus in breast cancerBreast Cancer Research and Treatment, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Estrogen Receptor β Inhibits Angiogenesis and Growth of T47D Breast Cancer XenograftsCancer Research, 2006
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997